Top News

Manipal Health IPO : ₹9,275 Crore Public Offer Details, GMP, and Brokerage Reviews—Should You Invest:
Samira Vishwas | July 29, 2026 8:24 PM CST

The healthcare sector’s blockbuster public offering is officially live as Manipal Health Enterprises launched its massive ₹9,275 crore Initial Public Offering for public subscription today, Wednesday, July 29, 2026. Running through July 31, the IPO has fixed a price band of ₹560 to ₹590 per equity share. Retail investors can bid for a minimum lot size of 25 shares, which requires a total investment of ₹14,750 at the upper price band. As one of the country’s premier healthcare giants hits the primary market, investors are closely examining gray market trends and expert brokerage recommendations to make informed investment decisions.

Gray Market Premium (GMP) and Market Sentiment

Ahead of its public launch, Manipal Health shares were commanding an unofficial gray market premium of around ₹13.5 per share on July 28. Based on these unverified trends, market observers estimate a potential debut listing price around the ₹603.5 mark, reflecting a modest premium of roughly 2.3% over the upper issue price limit. Financial experts caution that while GMP offers early insights into market sentiment, it remains an unofficial indicator that can fluctuate rapidly depending on broader secondary market trends and subscription rates during the three-day bidding window.

Expert Brokerage Recommendations: Subscribe or Avoid?

Major brokerage firms have shared diverse perspectives on the valuation and long-term growth potential of the hospital chain. SBI Securities has issued a definitive ‘Subscribe’ recommendation, citing the company’s dominant market footprint in major metropolitan hubs, aggressive expansion pipeline targeting 2,426 new beds by fiscal year 2030, and prospective margin expansions following debt reduction. Conversely, Angel One and Arihant Capital have adopted neutral stances. While both brokerages commended Manipal Health’s robust hospital network and successful inorganic growth strategy through acquisitions, they flagged concerns that the current pricing fully factors in the company’s premium valuation. Meanwhile, Emkay Global spotlighted the institution’s impressive nationwide reach and consistent revenue momentum without issuing a formal rating.

Company Profile and Market Standing

Manipal Health stands firmly as India’s largest private hospital chain when measured by licensed bed capacity. As of March 31, 2026, the enterprise operates an extensive network of 49 hospitals encompassing 13,037 licensed beds spread across 14 states and union territories. It also holds the position of India’s second-largest private hospital network by total number of hospitals and overall revenue generation. Furthermore, Manipal Health commands a formidable leadership advantage as the sole private healthcare operator holding the largest individual market shares simultaneously across key tier-1 metro hubs including Bengaluru, Kolkata, and Pune.


READ NEXT
Cancel OK